Todd Hulgan Selected Research

Inflammation (Inflammations)

1/2018	Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update.
1/2017	Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment.
11/2016	European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection.
1/2014	Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial.
7/2013	Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy.
1/2013	An association between adiposity and serum levels of macrophage inflammatory protein-1α and soluble CD14 in HIV-infected adults: results from a cross-sectional study.
6/2012	Serum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy.
4/2009	Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Todd Hulgan Research Topics

Disease

21	HIV Infections (HIV Infection) 07/2023 - 03/2005
21	Acquired Immunodeficiency Syndrome (AIDS) 12/2022 - 12/2004
8	Mitochondrial Diseases (Mitochondrial Disease) 07/2023 - 07/2006
8	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 09/2005
8	Inflammation (Inflammations) 01/2018 - 04/2009
6	Infections 11/2018 - 10/2003
5	Weight Gain 11/2023 - 12/2017
5	Neurocognitive Disorders (Clerambault Syndrome) 10/2021 - 04/2016
5	Hemochromatosis (Bronze Diabetes) 01/2020 - 07/2006
4	Insulin Resistance 11/2020 - 01/2018
4	Disease Progression 07/2011 - 09/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2013 - 12/2009
3	Polyneuropathies (Polyneuropathy) 07/2013 - 12/2008
2	Cognitive Dysfunction 07/2023 - 01/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 01/2021
2	Substance-Related Disorders (Drug Abuse) 04/2020 - 07/2017
2	Neuralgia (Stump Neuralgia) 01/2020 - 01/2014
2	Abdominal Obesity 01/2018 - 01/2014
2	Obesity 01/2018 - 07/2013
2	Marijuana Use 07/2017 - 01/2013
2	Neuroinflammatory Diseases 01/2017 - 11/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2016 - 11/2015
2	Anemia 04/2016 - 12/2013
2	Pain (Aches) 01/2014 - 12/2008
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Viremia 10/2021
1	Bronchitis 01/2021
1	Diabetes Mellitus 11/2020
1	Hepatitis C 01/2020
1	Frailty 01/2020
1	Coinfection 01/2020
1	Delirium 01/2019
1	Sepsis-Associated Encephalopathy 01/2019
1	Confusion (Bewilderment) 01/2019
1	Sepsis (Septicemia) 01/2019
1	Glucose Intolerance 01/2018
1	Dementia (Dementias) 04/2016
1	Hypersensitivity (Allergy) 01/2014

Drug/Important Bio-Agent (IBA)

18	Mitochondrial DNA (mtDNA)IBA 07/2023 - 04/2009
8	IronIBA 07/2023 - 07/2006
6	IntegrasesIBA 11/2023 - 01/2014
6	efavirenz (Sustiva)FDA Link 11/2023 - 12/2004
6	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2013
5	NucleosidesIBA 06/2010 - 09/2005
5	Reverse Transcriptase InhibitorsIBA 06/2010 - 09/2005
4	RNA (Ribonucleic Acid)IBA 04/2020 - 02/2007
4	C-Reactive ProteinIBA 01/2020 - 06/2012
4	Stavudine (Zerit)FDA LinkGeneric 01/2020 - 09/2005
4	Oxidants (Oxidizing Agents)IBA 01/2014 - 12/2003
3	dolutegravirIBA 11/2023 - 12/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2022 - 03/2005
3	Didanosine (Videx)FDA LinkGeneric 01/2020 - 08/2006
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2013
3	Zidovudine (Retrovir)FDA LinkGeneric 04/2016 - 08/2006
2	Raltegravir Potassium FDA Link 11/2023 - 01/2014
2	Integrase InhibitorsIBA 11/2023 - 10/2021
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 11/2023 - 10/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2021
2	Tenofovir (Viread)FDA Link 10/2021 - 12/2017
2	abacavir (Ziagen)FDA Link 10/2021 - 01/2014
2	Transferrin (beta 2 Transferrin)IBA 10/2021 - 01/2017
2	EicosanoidsIBA 01/2017 - 01/2014
2	Lipopolysaccharide ReceptorsIBA 07/2013 - 01/2013
2	CytokinesIBA 07/2013 - 04/2009
2	CholesterolIBA 07/2013 - 05/2008
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2009 - 10/2003
2	Nelfinavir (Viracept)FDA Link 03/2008 - 08/2006
2	Lamivudine (Epivir)FDA Link 03/2008 - 08/2006
2	DNA (Deoxyribonucleic Acid)IBA 07/2006 - 09/2005
1	elvitegravirIBA 11/2023
1	Iron-Binding ProteinsIBA 07/2023
1	AntioxidantsIBA 07/2023
1	Acetylcysteine (Siran)FDA LinkGeneric 07/2023
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2020
1	Ferritins (Ferritin)IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	AdiponectinIBA 01/2019
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2018
1	acylcarnitineIBA 01/2018
1	AcidsIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Branched-Chain Amino AcidsIBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	ThymidineIBA 01/2018
1	lamivudine drug combination abacavir FDA Link 12/2017
1	Emtricitabine (Emtriva)FDA Link 12/2017
1	RacivirIBA 12/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	Ceruloplasmin (Ferroxidase)IBA 01/2017
1	Telmisartan (Micardis)FDA Link 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	HLA-B57 antigenIBA 01/2014
1	Hemoglobins (Hemoglobin)IBA 12/2013
1	Viral ProteinsIBA 10/2013

Therapy/Procedure

29	Therapeutics 07/2023 - 10/2003
18	Art Therapy 11/2023 - 03/2008
13	Highly Active Antiretroviral Therapy (HAART) 07/2023 - 09/2005
1	Patient Admission (Patient Admissions) 01/2019
1	Ambulatory Care (Outpatient Care) 07/2017